Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Pier Luigi Zinzani, Monica Tani, Lapo Alinari, Anna Lia Molinari, Vittorio Stefoni, Giuseppe Visani, Patrizia Gentilini, Luciano Guardigni, Mariapaola Fina & Michele Baccarani. (2005) Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy. Leukemia & Lymphoma 46:10, pages 1449-1454.
Read now
Read now
Thomas R. Poskitt. (1987) Radiation Therapy and the Role of Red Blood Cell Transfusion. Cancer Investigation 5:3, pages 231-236.
Read now
Read now
Articles from other publishers (25)
Christina S. Chu & Stephen C. Rubin. 2023. DiSaia and Creasman Clinical Gynecologic Oncology. DiSaia and Creasman Clinical Gynecologic Oncology
443
463.e2
.
Christina S. Chu & Stephen C. Rubin. 2018. Clinical Gynecologic Oncology. Clinical Gynecologic Oncology
449
469.e2
.
Katharina T. Troppan, Thomas Melchardt, Alexander Deutsch, Konstantin Schlick, Tatjana Stojakovic, Marc D. Bullock, Daniel Reitz, Christine Beham-Schmid, Lukas Weiss, Daniel Neureiter, Kerstin Wenzl, Richard Greil, Peter Neumeister, Alexander Egle & Martin Pichler. (2015) The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients. European Journal of Haematology 95:6, pages 538-544.
Crossref
Crossref
K. Suzuki, Y. Terui, N. Nishimura, Y. Mishima, S. Sakajiri, M. Yokoyama, S. Takahashi, N. Tsuyama, K. Takeuchi & K. Hatake. (2012) Prognostic Value of C-reactive Protein, Lactase Dehydrogenase and Anemia in Recurrent or Refractory Aggressive Lymphoma. Japanese Journal of Clinical Oncology 43:1, pages 37-44.
Crossref
Crossref
Christina S. Chu & Stephen C. Rubin. 2012. Clinical Gynecologic Oncology. Clinical Gynecologic Oncology
515
538.e2
.
M. R. Nowrousian. 2008. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
149
188
.
M. R. Nowrousian. 2008. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
117
148
.
Christina S. Chu & Stephen C. Rubin. 2007. Clinical Gynecologic Oncology. Clinical Gynecologic Oncology
569
592
.
H. CLARKE & C. J. PALLISTER. (2005) The impact of anaemia on outcome in cancer. Clinical and Laboratory Haematology 27:1, pages 1-13.
Crossref
Crossref
Ashok Poluri, John Mores, Dane B. Cook, Thomas W. Findley & Adrian Cristian. (2005) Fatigue in the elderly population. Physical Medicine and Rehabilitation Clinics of North America 16:1, pages 91-108.
Crossref
Crossref
Paolo Tralongo, Daniela Respini & Francesco Ferraù. (2003) Fatigue and aging. Critical Reviews in Oncology/Hematology 48, pages S57-S64.
Crossref
Crossref
C Toriani-Terenzi, U Pozzetto, M Bianchi & E Fagiolo. (2002) Cytokine network in autoimmune haemolytic anaemia: new probable targets for therapy. Cancer Detection and Prevention 26:4, pages 292-298.
Crossref
Crossref
Aparna A. Bhanushali, R. Raghunathan, Rajiv D. Kalraiya & Narendra G. Mehta. (2002)
Cancer‐related anemia in a rat model: α
2
‐macroglobulin from Yoshida sarcoma shortens erythrocyte survival
. European Journal of Haematology 68:1, pages 42-48.
Crossref
Crossref
M. R. Nowrousian. 2002. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
39
62
.
M. R. Nowrousian. 2002. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
23
38
.
George Dranitsaris. (2016) The cost of blood transfusions in cancer patients: a reanalysis of a Canadian economic evaluation. Journal of Oncology Pharmacy Practice 6:2, pages 37-42.
Crossref
Crossref
I. Ray-CoquardA. Le CesneM. T. RubioJ. MermetC. MaugardA. RavaudC. ChevreauC. SebbanT. BachelotP. BironJ. Y. Blay. (1999) Risk Model for Severe Anemia Requiring Red Blood Cell Transfusion After Cytotoxic Conventional Chemotherapy Regimens. Journal of Clinical Oncology 17:9, pages 2840-2840.
Crossref
Crossref
Jerry L. Spivak. 1999. Clinical Applications of Cytokines and Growth Factors. Clinical Applications of Cytokines and Growth Factors
198
216
.
Ana Ortega, George Dranitsaris & Anitasha L. V. Puodziunas. (1998) What are cancer patients willing to pay for prophylactic epoetin alfa?. Cancer 83:12, pages 2588-2596.
Crossref
Crossref
I. Moullet, G. Salles, N. Ketterer, C. Dumontet, F. Bouafia, E.-M. Neidhart-Berard, C. Thieblemont, P. Felman & B. Coiffier. (1998) Frequency and significance of anemia in non-Hodgkin’s lymphoma patients. Annals of Oncology 9:10, pages 1109-1115.
Crossref
Crossref
Ana Ortega, George Dranitsaris & Anitasha Puodziunas. (2009) A Clinical and Economic Evaluation of Red Blood Cell Transfusions in Patients Receiving Cancer Chemotherapy. International Journal of Technology Assessment in Health Care 14:04, pages 788-798.
Crossref
Crossref
Pedro León, Miguel Jiménez, Pascual Barona & Luis Sierrasesúmaga. (1998) Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors. Medical and Pediatric Oncology 30:2, pages 110-116.
Crossref
Crossref
Michael Rytting, Laura Worth & Norman Jaffe. (1996) HEMOLYTIC DISORDERS ASSOCIATED WITH CANCER. Hematology/Oncology Clinics of North America 10:2, pages 365-376.
Crossref
Crossref
H. E. Kaiser. 1989. Local Invasion and Spread of Cancer. Local Invasion and Spread of Cancer
62
110
.
G S Masters, P Baines, R Bailey-Wood, T Gorvett, T Littlewood, P Bentley, H Parry-Jones & A Jacobs. (1987) Reduced in vitro erythroid progenitor cell growth in bronchial cancer.. Journal of Clinical Pathology 40:1, pages 87-93.
Crossref
Crossref